Dendritic cell vaccination combined with temozolomide retreatment: results of a phase I trial in patients with recurrent glioblastoma multiforme - Concepedia

Concepedia

Publication | Closed Access

Dendritic cell vaccination combined with temozolomide retreatment: results of a phase I trial in patients with recurrent glioblastoma multiforme

61

Citations

39

References

2014

Year

Martin K. Hunn, Evelyn Bauer, Catherine Wood, Olivier Gasser, Marina Dzhelali, Lindsay R. Ancelet, Brigitta Mester, Katrina Sharples, Michael Findlay, David A. Hamilton,

Journal of Neuro-Oncology

VaccinationNeuro-oncologyDendritic Cell VaccinationGliomaRecurrent Glioblastoma MultiformeImmunologyVaccine TrialTherapeutic VaccineImmune Checkpoint InhibitorPrecision VaccineHigh-grade GliomasImmunotherapyMedicineRadiation OncologyTumor MicroenvironmentTemozolomide Retreatment

References

	Year	Citations

Page 1

Page 1